WallStreetZenWallStreetZen

NASDAQ: XAIR
Beyond Air Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for XAIR

Based on 2 analysts offering 12 month price targets for Beyond Air Inc

Min Forecast
$10.00+218.47%
Avg Forecast
$105.00+3,243.95%
Max Forecast
$200.00+6,269.43%

Should I buy or sell XAIR stock?

Based on 2 analysts offering ratings for Beyond Air Inc.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their XAIR stock forecasts and price targets.

XAIR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-01
lockedlocked$00.00+00.00%2026-03-27

1 of 1

Forecast return on equity

Is XAIR forecast to generate an efficient return?

Company
-2,641.28%
Industry
22.17%
Market
168.87%
XAIR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is XAIR forecast to generate an efficient return on assets?

Company
-160.37%
Industry
13.69%
XAIR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

XAIR earnings per share forecast

What is XAIR's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$6.60
Avg 2 year Forecast
-$3.78
Avg 3 year Forecast
-$55.08

XAIR revenue forecast

What is XAIR's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$17.8M+131.3%
Avg 2 year Forecast
$34.9M+353.81%
Avg 3 year Forecast
$64.5M+738.74%
XAIR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

XAIR revenue growth forecast

How is XAIR forecast to perform vs Medical Devices companies and vs the US market?

Company
100.97%
Industry
7.24%
Market
13.54%
XAIR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XAIR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XAIR vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
XAIR$3.14$105.00+3,243.95%Strong Buy
FEED$3.35N/AN/A
NUWE$0.80N/AN/A
VVOS$0.18$2.80+1,481.92%Buy
VTAK$0.17N/AN/A
View Top Medical Device Stocks

Beyond Air Stock Forecast FAQ

Is Beyond Air Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: XAIR) stock is to Strong Buy XAIR stock.

Out of 2 analysts, 2 (100%) are recommending XAIR as a Strong Buy, 0 (0%) are recommending XAIR as a Buy, 0 (0%) are recommending XAIR as a Hold, 0 (0%) are recommending XAIR as a Sell, and 0 (0%) are recommending XAIR as a Strong Sell.

If you're new to stock investing, here's how to buy Beyond Air stock.

What is XAIR's earnings growth forecast for 2027-2029?

(NASDAQ: XAIR) Beyond Air's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 22.04%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.19%.

Beyond Air's earnings in 2026 is -$33,493,000.On average, 3 Wall Street analysts forecast XAIR's earnings for 2027 to be -$6,319,790, with the lowest XAIR earnings forecast at -$6,071,955, and the highest XAIR earnings forecast at -$6,505,666. On average, 3 Wall Street analysts forecast XAIR's earnings for 2028 to be -$3,623,867, with the lowest XAIR earnings forecast at -$3,481,755, and the highest XAIR earnings forecast at -$3,730,452.

In 2029, XAIR is forecast to generate -$52,746,315 in earnings, with the lowest earnings forecast at -$50,677,833 and the highest earnings forecast at -$54,297,678.

What is XAIR's revenue growth forecast for 2027-2029?

(NASDAQ: XAIR) Beyond Air's forecast annual revenue growth rate of 100.97% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.24%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.54%.

Beyond Air's revenue in 2026 is $7,687,000.On average, 3 Wall Street analysts forecast XAIR's revenue for 2027 to be $17,026,679, with the lowest XAIR revenue forecast at $16,358,253, and the highest XAIR revenue forecast at $17,527,520. On average, 3 Wall Street analysts forecast XAIR's revenue for 2028 to be $33,406,000, with the lowest XAIR revenue forecast at $32,095,961, and the highest XAIR revenue forecast at $34,388,529.

In 2029, XAIR is forecast to generate $61,742,301 in revenue, with the lowest revenue forecast at $59,321,410 and the highest revenue forecast at $63,558,927.

What is XAIR's forecast return on assets (ROA) for 2027-2029?

(NASDAQ: XAIR) forecast ROA is -160.37%, which is lower than the forecast US Medical Devices industry average of 13.69%.

What is XAIR's Price Target?

According to 2 Wall Street analysts that have issued a 1 year XAIR price target, the average XAIR price target is $105.00, with the highest XAIR stock price forecast at $200.00 and the lowest XAIR stock price forecast at $10.00.

On average, Wall Street analysts predict that Beyond Air's share price could reach $105.00 by Sep 1, 2027. The average Beyond Air stock price prediction forecasts a potential upside of 3,243.95% from the current XAIR share price of $3.14.

What is XAIR's Earnings Per Share (EPS) forecast for 2027-2029?

(NASDAQ: XAIR) Beyond Air's current Earnings Per Share (EPS) is -$64.00. On average, analysts forecast that XAIR's EPS will be -$6.60 for 2027, with the lowest EPS forecast at -$6.34, and the highest EPS forecast at -$6.79. On average, analysts forecast that XAIR's EPS will be -$3.78 for 2028, with the lowest EPS forecast at -$3.64, and the highest EPS forecast at -$3.90. In 2029, XAIR's EPS is forecast to hit -$55.08 (min: -$52.92, max: -$56.70).

What is XAIR's forecast return on equity (ROE) for 2027-2029?

(NASDAQ: XAIR) forecast ROE is -2,641.28%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.